REGISTER NOW

ASTHMA

2024ERS0000238 HOTHOT

STUDY OUTLINE

The study aims to assess dupilumab, a type of biologic medicine given as shots just under the skin. The trial aims to:

• Predict who is most likely to develop high risk asthma in coming years
• Prevent asthma attacks before they set in
• Reduce the need for daily inhaler therapy

• Predicting who can be effectively treated with an injection every two weeks instead of a daily inhaler.

To find out if this trial is suitable for you, please register below, or contact our Clinical Trials Team
on 6151 0813 or email clinicaltrials@resphealth.uwa.edu.au

ELIGIBILITY & REQUIREMENTS

  • Aged 18 to 80 years old
  • Have asthma
  • Currently taking medication for asthma.

WHAT'S INVOLVED

• The trial will run for 70 weeks
• 7 clinic visits to the Institute for Respiratory Health in Nedlands, Perth
• A full health check by our doctors and nurses
• Reimbursement for travel expenses
• Personalised health care with our doctors and nurses.





















Scroll to Top